-
1
-
-
34548595472
-
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials
-
DOI 10.1093/ije/dym087
-
Pildal J, Hrobjartsson A, Jorgensen KJ, et al. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. IntJ Epidemiol 2007;36:847-57. (Pubitemid 47394153)
-
(2007)
International Journal of Epidemiology
, vol.36
, Issue.4
, pp. 847-857
-
-
Pildal, J.1
Hrobjartsson, A.2
Jorgensen, K.J.3
Hilden, J.4
Altman, D.G.5
Gotzsche, P.C.6
-
2
-
-
84868308325
-
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials
-
Savovic J, Jones HE, Altman DG, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 2012.
-
(2012)
Ann Intern Med
-
-
Savovic, J.1
Jones, H.E.2
Altman, D.G.3
-
4
-
-
52649129348
-
Systematic review of the empirical evidence of study publication bias and outcome reporting bias
-
Dwan K, Altman DG, Arnaiz JA, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 2008;3:e30-81.
-
(2008)
PLoS ONE
, vol.3
-
-
Dwan, K.1
Altman, D.G.2
Arnaiz, J.A.3
-
5
-
-
84856004859
-
Classification systems to improve assessment of risk of bias
-
Boutron I, Ravaud P. Classification systems to improve assessment of risk of bias. J Clin Epidemiol 2012;65:236-8.
-
(2012)
J Clin Epidemiol
, vol.65
, pp. 236-238
-
-
Boutron, I.1
Ravaud, P.2
-
7
-
-
0345583669
-
The hazards of scoring the quality of clinical trials for meta-analysis
-
DOI 10.1001/jama.282.11.1054
-
Juni P, Witschi A, Bloch R, et al. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60. (Pubitemid 29436453)
-
(1999)
Journal of the American Medical Association
, vol.282
, Issue.11
, pp. 1054-1060
-
-
Juni, P.1
Witschi, A.2
Bloch, R.3
Egger, M.4
-
8
-
-
0035822324
-
Systematic reviews in health care: Assessing the quality of controlled clinical trials
-
Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-6. (Pubitemid 32682008)
-
(2001)
British Medical Journal
, vol.323
, Issue.7303
, pp. 42-46
-
-
Juni, P.1
Altman, D.G.2
Egger, M.3
-
9
-
-
69449100622
-
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
-
(2009)
BMJ
, vol.339
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
-
10
-
-
69149107727
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration
-
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94.
-
(2009)
Ann Intern Med
, vol.151
-
-
Liberati, A.1
Altman, D.G.2
Tetzlaff, J.3
-
11
-
-
43049113533
-
GRADE: An emerging consensus on rating quality of evidence and strength of recommendations
-
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. (Pubitemid 351632017)
-
(2008)
BMJ
, vol.336
, Issue.7650
, pp. 924-926
-
-
Guyatt, G.H.1
Oxman, A.D.2
Vist, G.E.3
Kunz, R.4
Falck-Ytter, Y.5
Alonso-Coello, P.6
Schunemann, H.J.7
-
12
-
-
79951955368
-
GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias)
-
Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol 2011;64:407-15.
-
(2011)
J Clin Epidemiol
, vol.64
, pp. 407-415
-
-
Guyatt, G.H.1
Oxman, A.D.2
Vist, G.3
-
13
-
-
84859001212
-
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
-
Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
-
(2011)
BMJ
, vol.343
-
-
Higgins, J.P.1
Altman, D.G.2
Gotzsche, P.C.3
-
14
-
-
0029914622
-
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
-
DOI 10.1016/0197-2456(95)00134-4
-
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. (Pubitemid 26120810)
-
(1996)
Controlled Clinical Trials
, vol.17
, Issue.1
, pp. 1-12
-
-
Jadad, A.R.1
Moore, R.A.2
Carroll, D.3
Jenkinson, C.4
Reynolds, D.J.M.5
Gavaghan, D.J.6
McQuay, H.J.7
-
15
-
-
43549092286
-
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies
-
Lundh A, Gotzsche PC. Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol 2008;8:22.
-
(2008)
BMC Med Res Methodol
, vol.8
, pp. 22
-
-
Lundh, A.1
Gotzsche, P.C.2
-
16
-
-
70049099036
-
Chapter 8: Assessing risk of bias in included studies
-
Higgins JPT, Green S. eds, updated March 2011, The Cochrane Collaboration
-
Higgins JP, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S. eds Cochrane handbook for systematic reviews of interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org and http://www.cochrane-handbook.org
-
(2011)
Cochrane Handbook for Systematic Reviews of Interventions 5.1.0
-
-
Higgins, J.P.1
Altman, D.G.2
-
17
-
-
21044459830
-
Assessment of methodological quality of primary studies by systematic reviews: Results of the metaquality cross sectional study
-
Moja LP, Telaro E, D'Amico R, et al. Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ 2005;330:1053.
-
(2005)
BMJ
, vol.330
, pp. 1053
-
-
Moja, L.P.1
Telaro, E.2
D'Amico, R.3
-
18
-
-
77957859521
-
Seventy-five trials and eleven systematic reviews a day: How will we ever keep up?
-
Bastian H, Glasziou P, Chalmers I. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?. PLoS Med 2010;7:e1000326.
-
(2010)
PLoS Med
, vol.7
-
-
Bastian, H.1
Glasziou, P.2
Chalmers, I.3
-
19
-
-
33947684405
-
Epidemiology and reporting characteristics of systematic reviews
-
Moher D, Tetzlaff J, Tricco AC, et al. Epidemiology and reporting characteristics of systematic reviews. PLoS Med 2007;4:e78.
-
(2007)
PLoS Med
, vol.4
-
-
Moher, D.1
Tetzlaff, J.2
Tricco, A.C.3
-
20
-
-
0032527547
-
Methodology and reports of systematic reviews and meta-analyses. A comparison of cochrane reviews with articles published in paper-based journals
-
DOI 10.1001/jama.280.3.278
-
Jadad AR, Cook DJ, Jones A, et al. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998;280:278-80. (Pubitemid 28493907)
-
(1998)
Journal of the American Medical Association
, vol.280
, Issue.3
, pp. 278-280
-
-
Jadad, A.R.1
Cook, D.J.2
Jones, A.3
Klassen, T.P.4
Tugwell, P.5
Moher, M.6
Moher, D.7
|